title: Despite warnings, drug giant took long path to Vioxx recall.
authors.forename: Alex
authors.initials: A
authors.lastname: Berenson
authors.forename: Gardiner
authors.initials: G
authors.lastname: Harris
authors.forename: Barry
authors.initials: B
authors.lastname: Meier
authors.forename: Andrew
authors.initials: A
authors.lastname: Pollack
mesh_terms: D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D016365:Liability, Legal; D009203:Myocardial Infarction / Q000139:chemically induced; D011358:Product Surveillance, Postmarketing; D013450:Sulfones; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007783:Lactones; D013450:Sulfones; C116926:rofecoxib